… drugs.  Key advanced liver cancer companies such as Polaris Pharmaceuticals, Shanghai Henlius Biotech … advanced liver cancer clinical trials. In June 2025, … III trial for the first-line treatment of … or nivolumab plus ipilimumab offering meaningful survival …

… clinical trial provided new insight into first-line treatment for … and PD-1 inhibitors (ipilimumab and nivolumab) to various … to standard-of-care treatments (68%). Secondary outcomes … and toxicity leading to treatment discontinuation occurred more frequently …

… renal cell carcinoma present unique treatment challenges requiring careful consideration of … years has transformed favorable-risk treatment paradigms. Tykodi emphasizes reduced … risk patients initially showed an ipilimumab plus nivolumab disadvantage, but …

… resists conventional treatments. Microcatheter-assisted drug-loaded microspheres … trial assessed the efficacy of nivolumab combined with ipilimumab … doi:10.3390/pharmaceutics14020359. 10. Nicoletti R, … al. Intradermal DNA vaccination combined with dual CTLA …

… Reserve University School of Medicine, and director of the … the LEAP-002 trial (NCT03713593). In both trials, the median overall … in ipilimumab/nivolumab becoming an approved first-line treatment in … be using a particular drug, and in this particular …

… timely, confident, and data-driven treatment decisions when every moment counts … phase 3 trial supported the FDA approval of nivolumab plus ipilimumab in patients … Hersey, vice president of Precision Medicine, Bioanalytical and Translational Sciences at …

… New Approach to Treatment for Peritoneal Mesothelioma The medical team approached … patient received nivolumab (Opdivo®) and ipilimumab (Yervoy®) to attack the tumor … top resources on nearby doctors, treatment options, clinical trials, support groups, and …

… Back to Healio The FDA has approved the Idylla … who may benefit from treatment with nivolumab (Opdivo, … with ipilimumab (Yervoy, Bristol Myers Squibb). The FDA has … treatment decisions when every moment counts,” Michael Korn, MD, Biocartis’ chief medical …

… of ipilimumab and nivolumab as frontline treatment … investigations that inform FDA approvals, clinical … thereby accelerating personalized medicine. Collectively, the … Trials in OncologyASCO Annual Meeting 2025cancer treatment advancementsclinical trial …

Panelists discuss how treatment selection for a typical intermediate- … carcinoma (RCC) involves choosing between ipilimumab plus nivolumab for long-term …